Loading...
Loading...
India's dasatinib imports from UNITED STATES total $2.5M across 47 shipments from 15 foreign suppliers. M/S ESPEE BIOPHARMA & FINECHEM LLC leads with $901.3K in import value; the top 5 suppliers together control 84.1% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for dasatinib — a diversified sourcing base with multiple active suppliers from UNITED STATES.

M/S ESPEE BIOPHARMA & FINECHEM LLC is the leading Dasatinib supplier from UNITED STATES to India, with import value of $901.3K across 7 shipments. The top 5 suppliers — M/S ESPEE BIOPHARMA & FINECHEM LLC, ESPEE BIOPHARMA AND FINECHEM LLC, AMSTERDAM PHARMA(APTEKA RX INC.), ESPEE BIOPHARMA & FINECHEM LLC, AGRACE PHARMA — collectively account for 84.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $901.3K | 7 | 36.5% |
| 2 | ESPEE BIOPHARMA AND FINECHEM LLC | $503.3K | 7 | 20.4% |
| 3 | AMSTERDAM PHARMA(APTEKA RX INC.) | $251.6K | 8 | 10.2% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $220.8K | 1 | 8.9% |
| 5 | AGRACE PHARMA | $203.3K | 1 | 8.2% |
| 6 | AMSTERDAM PHARMA APTEKA RX INC | $103.5K | 1 | 4.2% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC. | $93.2K | 6 | 3.8% |
| 8 | INWOOD PHARMA INC. | $80.2K | 5 | 3.2% |
| 9 | AMSTERDAM PHARMA | $35.5K | 1 | 1.4% |
| 10 | SUN FARMACEUTICA DO BRASIL LIMITEDA | $34.4K | 2 | 1.4% |
| 11 | ACCORD FARMACEUTCA LTDA | $23.1K | 1 | 0.9% |
| 12 | XXRMAXXND XXRMOXXOM XXOD XXDA | $21.0K | 1 | 0.9% |
| 13 | HANDA ONCOLOGY LLC. | $734 | 4 | 0.0% |
| 14 | M/S. HANDA ONCOLOGY LLC | $218 | 1 | 0.0% |
| 15 | CELL SIGNALING TECHNOLOGY | $53 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $901.3K | 7 | 36.5% |
| 2 | USV PRIVATE LIMITED | $799.8K | 14 | 32.4% |
| 3 | DR.REDDY'S LABORATORIES LTD | $234.5K | 7 | 9.5% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED | $220.8K | 1 | 8.9% |
| 5 | DR REDDYS LABORATORIES LIMITED | $103.5K | 1 | 4.2% |
| 6 | GLENMARK PHARMACEUTICALS LIMITED | $80.2K | 5 | 3.2% |
| 7 | QPS BIOSERVE INDIA PRIVATE LIMITED | $36.5K | 6 | 1.5% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $34.4K | 2 | 1.4% |
| 9 | INTAS PHARMACEUTICALS LIMITED | $23.1K | 1 | 0.9% |
| 10 | BIOCON PHARMA LIMITED | $21.0K | 1 | 0.9% |
| 11 | DR.REDDY'S LABORATORIES LIMITED | $17.1K | 1 | 0.7% |
| 12 | IMPERIAL LIFE SCIENCES PRIVATE LIMITED | $53 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dasatinib suppliers from UNITED STATES to India include M/S ESPEE BIOPHARMA & FINECHEM LLC, ESPEE BIOPHARMA AND FINECHEM LLC, AMSTERDAM PHARMA(APTEKA RX INC.). The leading supplier is M/S ESPEE BIOPHARMA & FINECHEM LLC with import value of $901.3K USD across 7 shipments. India imported Dasatinib worth $2.5M USD from UNITED STATES in total across 47 shipments.
India imported Dasatinib worth $2.5M USD from UNITED STATES across 47 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dasatinib sourced from UNITED STATES include MSN LABORATORIES PRIVATE LIMITED, USV PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $901.3K in imports across 7 shipments.
The total value of Dasatinib imports from UNITED STATES to India is $2.5M USD, across 47 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
47 Verified Shipments
15 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists